Triple-negative Breast Cancer: What Have We Learned, How Can We Innovate?

Triple-negative Breast Cancer: What Have We Learned, How Can We Innovate?

January 25, 2018

Address

727 E. Tyler St.
Tempe, AZ 85287

Location

Biodesign Institute, Auditorium

Date and Time

January 31, 2018, 12:00 pm (Length: 1 hour 0 minutes)

iCal Download

Presented by Jasgit Sachdev, M.D., Medical Oncologist and Clinical Trial Investigator, Virginia G. Piper Cancer Center Clinical Trials, Honor Health Research Institute


Jasgit Sachdev leads the Honor Health Research Institute program in new drug development for breast and gynecologic cancers and has been actively engaged in clinical and translational research with a particular focus in triple negative breast cancer. She has served as the principal investigator on several cooperative group, industry and investigator initiated clinical trials. She consults on patients with breast and gynecologic cancers and evaluates them for phase I trials of novel agents with potential activity in these malignancies.

Host: Biodesign Center for Immunotherapy, Vaccines and Virotherapy